Nuclear Medicine: Page 13

Telix touts studies at EANM 2023
By AuntMinnie.com staff writers
Telix Pharmaceuticals is highlighting studies set to be presented at the European Association of Nuclear Medicine meeting to be held September 9-13 in Vienna.
September 5, 2023
2018 12 11 00 02 7009 Atom Nuclear Lab 400
Actinium to present three abstracts at SOHO 2023
By AuntMinnie.com staff writers
Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.
August 30, 2023
2020 07 23 21 58 4280 Cancer Radiotherapy 400
TerraPower, PanTera sign agreement for Ac-225 production
By AuntMinnie.com staff writers
TerraPower Isotopes and PanTera signed a strategic collaboration that they say will increase the global availability of actinium-225 (Ac-225), a radioisotope that may prove able to treat a large variety of cancer indications.
August 30, 2023
2021 09 14 23 49 7847 Business Handshake 400
Staff safety at risk during Y-90 radioembolizations
By Will Morton
Contamination during yttrium-90 (Y-90) radioembolization procedures can lead to significant radiation exposure for medical personnel, according to a study published August 16 in the Journal of Nuclear Medicine Technology.
August 22, 2023
2023 08 22 15 49 8157 2023 08 22 Y 90 Dose Exposure 20230822155246
AI developed for SPECT kidney imaging in children
By Will Morton
An AI model based on SPECT images has the potential to help nuclear medicine physicians identify kidney defects in children, according to a research group in Taiwan.
August 16, 2023
2016 08 23 17 04 30 620 Kidney 400
AI outperforms clinical scores in high-risk lymphoma patients
By Will Morton
Researchers have developed an AI algorithm for reading FDG-PET/CT scans that outperforms standard clinical scores used to identify high-risk lymphoma patients, according to a study published August 12 in Scientific Reports.
August 15, 2023
2023 08 15 20 59 1662 2023 08 15 Ai Lymphoma 20230815200315
AI could help evaluate brain tumors on PET
By Will Morton
A group in Germany has developed an AI model for PET imaging that could help clinicians determine whether patients are responding to brain tumor treatments, according to a study published August 10 in the Journal of Nuclear Medicine.
August 14, 2023
2023 08 14 20 11 1810 2023 08 14 Pet Ai 400
TeraRecon adds Mirada's MiradaXD to its AI partner program
By AuntMinnie.com staff writers
ConcertAI subsidiary TeraRecon has added imaging software developer Mirada Medical's Mirada XD nuclear medicine imaging software to its AI partner program.
August 1, 2023
2021 03 11 21 54 5662 Computer Ai Artificial Illustration 400
Pilot(less) study: Drones can deliver medical isotopes
By Will Morton
Cargo drones carrying medical isotopes could become an integral part of radiopharmaceutical supply chains, according to research presented July 26 at the International Conference on Isotopes meeting in Saskatoon, Saskatchewan, Canada.
July 26, 2023
2023 07 27 00 06 1652 2023 07 27 Isotope Drone 20230727010009
New PET radiotracer shows promise in NETs
By Will Morton
An experimental PET radiotracer shows promise for detecting metastatic cancer lesions in patients with neuroendocrine tumors, according to a study published July 20 in the Journal of Nuclear Medicine.
July 25, 2023
2023 07 25 22 44 8931 2023 07 25 Pet Nets 20230725225340
Ramsoft and Miranda Medical to establish partnership
By AuntMinnie.com staff writers
PACS vendor RamSoft and imaging software developer Mirada Medical plan to partner on a radiation therapy treatment package.
July 24, 2023
2022 06 28 17 16 2885 Hands Shaking3 20230509203239
Clarity reaches 50% recruitment for SABRE trial
By AuntMinnie.com staff writers
Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitment for its Phase II Copper-64 SAR-Bombesin in Biochemical REcurrence of Prostate Cancer (SABRE) trial.
July 23, 2023
2019 04 17 20 48 2514 Prostate 3 D 400
Previous Page
Page 13 of 445
Next Page